Back to STIFEL FINANCIAL CORP

CUE
Showing 8 of 28 quarters

Position history for STIFEL FINANCIAL CORP's holdings in CUE BIOPHARMA INC

STIFEL FINANCIAL CORP holds 246,556 shares of CUE (CUE BIOPHARMA INC), worth $56,683 as of 2026-Q1. CUE represents 0.0% of STIFEL FINANCIAL CORP's portfolio.

Current Value

$56,683

Current Shares

246,556

Total Value Change

-$183,863

Total Shares Change

+52,566

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Unchanged
246,556
0.0%
$56,6830.0%$0.30
0
2025-Q4
Increased
246,556
+25.4%
$75,2980.0%$0.30
26
2025-Q3
Unchanged
196,556
0.0%
$141,2650.0%$0.72
0
2025-Q2
Decreased
196,556
-3.5%
$134,1100.0%$0.74
0
2025-Q1
Decreased
203,578
-3.7%
$185,4600.0%$0.92
0
2024-Q4
Increased
211,361
+8.8%
$230,3830.0%$1.02
25
2024-Q3
Increased
194,222
+0.1%
$147,0670.0%$0.68
22
2024-Q2
Increased
193,990
+0.7%
$240,5460.0%$1.24
23

Other major holders of CUE: Avoro Capital Advisors LLC, Woodline Partners LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used